Skip to main content

CORRECTION article

Front. Oncol., 20 April 2021
Sec. Gastrointestinal Cancers
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.672599

Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer

This article is a correction to:

  1. Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer

    1. Read original article
Huifang LvHuifang Lv1Junling ZhangJunling Zhang2Keran SunKeran Sun1Caiyun NieCaiyun Nie1Beibei ChenBeibei Chen1Jianzheng WangJianzheng Wang1Weifeng XuWeifeng Xu1Saiqi WangSaiqi Wang1Yingjun LiuYingjun Liu3Xiaobing Chen*Xiaobing Chen1*
  • 1Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
  • 2Medical Department, 3D Medicines Inc., Shanghai, China
  • 3Department of Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China

A Corrigendum on
Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer

By Lv H, Zhang J, Sun K, Nie C, Chen B, Wang J, Xu W, Wang S, Liu Y, Chen X. Front Oncol. 2021 Feb 1;10:580045. doi: 10.3389/fonc.2020.580045

In the published article, there was an error regarding the affiliation(s) for Huifang Lv, Keran Sun, Caiyun Nie, Beibei Chen, Jianzheng Wang, Weifeng Xu, Saiqi Wang, and Xiaobing Chen. As well as having affiliation(s) Department of Oncology, Henan Cancer Hospital, Zhengzhou, China, they should also have Department of Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China.

In the published article, there was an error regarding the affiliation for Yingjun Liu. As well as having affiliation(s) Department of Surgery, Henan Cancer Hospital, Zhengzhou, China, the author should also have Department of Surgery, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China.

The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: HER-2, PD-L1, prognosis, gastric cancer, CD8+T cells

Citation: Lv H, Zhang J, Sun K, Nie C, Chen B, Wang J, Xu W, Wang S, Liu Y and Chen X (2021) Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer. Front. Oncol. 11:672599. doi: 10.3389/fonc.2021.672599

Received: 26 February 2021; Accepted: 03 March 2021;
Published: 20 April 2021.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Lv, Zhang, Sun, Nie, Chen, Wang, Xu, Wang, Liu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiaobing Chen, chenxbxh@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.